| FRANKLIN ALTERNATIVE STRATEGIES W (ACC) EUR | RENT. ABSOLUTA. | 18,020000 | · | · | 25/06/2026 |
| FRANKLIN ALTERNATIVE STRATEGIES W (ACC) EUR-H1 | RENT. ABSOLUTA. | 11,870000 | · | · | 25/06/2026 |
| FRANKLIN ALTERNATIVE STRATEGIES W (ACC) GBP-H1 | RENT. ABSOLUTA. | 17,091538 | · | · | 25/06/2026 |
| FRANKLIN ALTERNATIVE STRATEGIES W (ACC) USD | RENT. ABSOLUTA. | 13,410333 | · | · | 25/06/2026 |
| FRANKLIN ALTERNATIVE STRATEGIES W (YDIS) EUR-H1 | RENT. ABSOLUTA. | 10,860000 | · | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) CHF-H1 | RVI BIOTECNOLOGÍA | 26,423073 | · | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 18,850000 | · | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 4,942200 | · | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) SGD | RVI BIOTECNOLOGÍA | 43,141518 | 7.214,710000 | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 59,310527 | 79.653,760000 | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 39,530000 | · | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) USD | RVI BIOTECNOLOGÍA | 95,979545 | 4.299,680000 | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY N (ACC) USD | RVI BIOTECNOLOGÍA | 48,333627 | 5.172,640000 | · | 25/06/2026 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY W (ACC) USD | RVI BIOTECNOLOGÍA | 29,959443 | · | · | 25/06/2026 |
| FRANKLIN DISRUPTIVE COMMERCE A (ACC) USD | RVI CONSUMO | 5,510492 | · | · | 25/06/2026 |
| FRANKLIN DISRUPTIVE COMMERCE A (YDIS) EUR | RVI CONSUMO | 6,370000 | · | · | 25/06/2026 |
| FRANKLIN DISRUPTIVE COMMERCE C (ACC) USD | RVI CONSUMO | 5,360607 | · | · | 25/06/2026 |
| FRANKLIN DISRUPTIVE COMMERCE I (ACC) EUR | RVI CONSUMO | 6,650000 | · | · | 25/06/2026 |
| FRANKLIN DISRUPTIVE COMMERCE I (ACC) USD | RVI CONSUMO | 5,757362 | · | · | 25/06/2026 |
| FRANKLIN DISRUPTIVE COMMERCE N (ACC) EUR | RVI CONSUMO | 6,150000 | · | · | 25/06/2026 |
